Schonfeld Strategic Advisors LLC Castle Biosciences Inc Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 56,000 shares of CSTL stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

56,000

Previous 51,247 9.27%

Holding current value

$1.41 Million

Previous $1.12 Million 43.23%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $82,702 - $149,576	4,753 Added 9.27%	56,000 $1.6 Million
Q2 2024 Aug 14, 2024	SELL	$18.84 - $24.94 $2.15 Million - $2.85 Million	-114,194 Reduced 69.02%	51,247 $1.12 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $74,786 - $104,767	4,141 Added 2.57%	165,441 $3.66 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $161,761 - $297,646	13,270 Added 8.96%	161,300 $3.48 Million
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $1.47 Million - $2.24 Million	110,500 Added 294.43%	148,030 $2.5 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $137,424 - $306,436	11,786 Added 45.78%	37,530 $514,000
Q1 2023 May 15, 2023	SELL	$19.47 - $28.49 $617,491 - $903,560	-31,715 Reduced 55.2%	25,744 $584,000
Q4 2022 Feb 14, 2023	SELL	$18.08 - $30.0 $1.97 Million - $3.27 Million	-108,935 Reduced 65.47%	57,459 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $30,816 - $46,984	-1,369 Reduced 0.82%	166,394 $4.34 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $1.7 Million - $4.88 Million	106,059 Added 171.88%	167,763 $3.68 Million
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $682,970 - $967,318	20,590 Added 50.08%	61,704 $2.77 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $196,159 - $339,386	-5,022 Reduced 10.89%	41,114 $1.76 Million
Q3 2021 Nov 16, 2021	BUY	$60.13 - $77.6 $1.13 Million - $1.45 Million	18,723 Added 68.3%	46,136 $3.07 Million
Q2 2021 Nov 16, 2021	SELL	$50.07 - $76.78 $424,944 - $651,631	-8,487 Reduced 23.64%	27,413 $2.01 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $419,035 - $642,571	8,369 Added 30.4%	35,900 $2.63 Million
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $1.15 Million - $1.9 Million	19,531 Added 244.14%	27,531 $1.89 Million
Q4 2020 Feb 16, 2021	SELL	$43.6 - $73.05 $3.08 Million - $5.16 Million	-70,700 Reduced 89.83%	8,000 $538,000
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $2.43 Million - $3.29 Million	63,200 Added 407.74%	78,700 $4,000
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $422,840 - $666,655	15,500 New	15,500 $584,000

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $660M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Castle Biosciences Inc Transaction History